333
Participants
Start Date
December 31, 2013
Primary Completion Date
June 30, 2016
Study Completion Date
December 31, 2022
Nellix System
Subjects in this study will receive a Nellix Endovascular Sealing System as part of their intervention.
Rijnstate Hospital, Arnhem
Allegheny General Hospital, Pittsburgh
UPMC Heart and Vascular Institue, Pittsburgh
Christiana Care Hospital, Newark
MedStar Health Research Institute, Washington D.C.
Inova Fairfax Hospital, Falls Church
Carolinas Health Care, Charlotte
Sacred Heart, Pensacola
Baptist Hospital of Miami, Miami
Ohio Health Research Institute, Columbus
Cleveland Clinic, Cleveland
St. Vincent Heart Center of Indiana, Indianapolis
Spectrum Health, Grand Rapids
Froedtert Memorial Lutheran Hospital (Medical College of Wisconsin), Milwaukee
Minneapolis Hospital, Minneapolis
St. Vincent Heart and Vascular Center of Montana, Billings
Nebraska Heart Institute, Lincoln
The Heart Hospital Baylor Plano, Plano
Scott & White Healthcare System, Temple
St. Luke's Medical Center, Houston
Tucson Medical Center, Tucson
VA San Diego, San Diego
Providence Sacred Heart Medical Center, Spokane
Yale University, New Haven
Maine Medical Center, Portland
St. Elizabeth's Medical Center, Brighton
Bay State Hospital, Springfield
Cooper Hospital, Camden
University of Heidelberg, Heidelberg
Addenbrooke's Hospital, Cambridge
Lead Sponsor
Endologix
INDUSTRY